Kimberly Blackwell

Angel

Overview

Gender
female
Investor Type
Angel

Kimberly Blackwell is the current Chief Executive Officer and Board of Director of Zentalis Pharmaceuticals. She previously worked at Tempus as a Chief Medical Officer and SVP, Clinical Oncology Development. Kimberly Blackwell attended Duke University.

Personal Investments

Number of Investments
1
Kimberly Blackwell has made 1 investments. Their most recent investment was on Apr 13, 2022, when MoonPay raised $87M.
Date Company Name Round Money Raised Industry
Apr 13, 2022 MoonPay Series A $87M Financial Services Detail